Azenta Completes Sale of B Medical Systems for $63M

By Hao Liu • Wednesday, July 08 10:51 • Permanent Link

Azenta said it completed the sale of its B Medical Systems business to Thelema S.à r.l. on July 1, 2026, closing a deal first announced on Dec. 29, 2025.

The company said the business was sold for a fixed cash purchase price of $63 million. Of that amount, $35 million was funded through a short-term secured vendor loan from an Azenta subsidiary to Thelema.

Azenta said the transaction was completed after all closing conditions were satisfied. The company framed the divestiture as part of its effort to simplify its portfolio and concentrate on its core life sciences businesses. The market has reacted to these announcements by moving the company's shares -3.31% to a price of $24.53. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.